A first-in-human clinical study of an intranasal spray of a cocktail containing two synergetic antibodies neutralizes Omicron BA.4/5

Xinghai Zhang, Feiyang Luo, Huajun Zhang, Hangtian Guo, Junhui Zhou, Tingting Li, Shaohong Chen, Shuyi Song, Meiying Shen, Yan Wu, Yan Gao, Xiaojian Han, Yingming Wang, Chao Hu, Xiaodong Zhao, Huilin Guo, Dazhi Zhang, Yuchi Lu, Wei Wang, Kai Wang, Ni Tang, Tengchuan Jin, Menglu Ding, Shuhui Luo, Cuicui Lin, Tingting Lu, Bingxia Lu, Yang Tian, Chengyong Yang, Guofeng Cheng, Haitao Yang, Aishun Jin, Xiaoyun Ji, Rui Gong, Sandra Chiu, Ailong Huang
doi: https://doi.org/10.1101/2023.03.17.23287398

Article Information

doi 
https://doi.org/10.1101/2023.03.17.23287398
History 
  • March 20, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Xinghai Zhang1,†,
  2. Feiyang Luo2,3,†,
  3. Huajun Zhang1,†,
  4. Hangtian Guo4,7,†,
  5. Junhui Zhou1,5,†,
  6. Tingting Li2,3,†,
  7. Shaohong Chen1,5,†,
  8. Shuyi Song2,3,
  9. Meiying Shen6,
  10. Yan Wu1,
  11. Yan Gao7,8,
  12. Xiaojian Han2,3,
  13. Yingming Wang2,3,
  14. Chao Hu2,3,
  15. Xiaodong Zhao9,
  16. Huilin Guo9,
  17. Dazhi Zhang9,
  18. Yuchi Lu7,
  19. Wei Wang10,
  20. Kai Wang11,
  21. Ni Tang11,
  22. Tengchuan Jin12,
  23. Menglu Ding13,
  24. Shuhui Luo13,
  25. Cuicui Lin13,
  26. Tingting Lu13,
  27. Bingxia Lu13,
  28. Yang Tian13,
  29. Chengyong Yang13,
  30. Guofeng Cheng13,*,
  31. Haitao Yang7,8,*,
  32. Aishun Jin2,3,*,
  33. Xiaoyun Ji4,10,14,*,
  34. Rui Gong1,*,
  35. Sandra Chiu12,* and
  36. Ailong Huang11,*
  1. 1CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei 430071, China
  2. 2Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400010, China
  3. 3Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing 400010, China
  4. 4The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Institute of Viruses and Infectious Diseases, Chemistry and Biomedicine Innovation Center (ChemBIC), Institute of Artificial Intelligence Biomedicine, Nanjing University, Nanjing 210023, China
  5. 5University of Chinese Academy of Sciences, Beijing 100049, China
  6. 6Department of Endocrine Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
  7. 7Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, Shanghai Tech University, Shanghai 201210, China
  8. 8Shanghai Clinical Research and Trial Center, Shanghai 201210, China
  9. 9The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China
  10. 10Institute of Life Sciences, Chongqing Medical University, Chongqing 400010, China
  11. 11Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010 China
  12. 12Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230026, China
  13. 13Mindao Haoyue Co., Ltd., SQ0042 Lanyuan Hall, No.61 Daxuecheng Middle Road, Chongqing, 400042 China
  14. 14Engineering Research Center of Protein and Peptide Medicine, Ministry of Education, Nanjing 210023, China
  1. ↵*Corresponding authors: Haitao Yang (yanght{at}shanghaitech.edu.cn), Aishun Jin (aishunjin{at}cqmu.edu.cn), Xiaoyun Ji (xiaoyun.ji{at}nju.edu.cn), Rui Gong (gongr{at}wh.iov.cn), Sandra Chiu (qiux{at}ustc.edu.cn), Ailong Huang (ahuang{at}cqmu.edu.cn)

  1. ↵† These authors contributed equally to this work.

Back to top
Posted March 20, 2023.
Download PDF
Data/Code
Email
A first-in-human clinical study of an intranasal spray of a cocktail containing two synergetic antibodies neutralizes Omicron BA.4/5
Xinghai Zhang, Feiyang Luo, Huajun Zhang, Hangtian Guo, Junhui Zhou, Tingting Li, Shaohong Chen, Shuyi Song, Meiying Shen, Yan Wu, Yan Gao, Xiaojian Han, Yingming Wang, Chao Hu, Xiaodong Zhao, Huilin Guo, Dazhi Zhang, Yuchi Lu, Wei Wang, Kai Wang, Ni Tang, Tengchuan Jin, Menglu Ding, Shuhui Luo, Cuicui Lin, Tingting Lu, Bingxia Lu, Yang Tian, Chengyong Yang, Guofeng Cheng, Haitao Yang, Aishun Jin, Xiaoyun Ji, Rui Gong, Sandra Chiu, Ailong Huang
medRxiv 2023.03.17.23287398; doi: https://doi.org/10.1101/2023.03.17.23287398
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area